Successful treatment of an infant with CDA type II by intrauterine transfusions and postnatal stem cell transplantation

Pediatr Blood Cancer. 2014 Apr;61(4):743-5. doi: 10.1002/pbc.24786. Epub 2013 Oct 3.

Abstract

Congenital dyserythropoietic anemias are rare hematological disorders leading to ineffective erythropoiesis with chronic anemia, complicated by iron overload. Here we present a remarkable clinical course of an infant with CDA type II who first presented as a severe fetal hydrops, requiring serial intrauterine red cell transfusions. While postnatal transfusion dependency persisted, the patient was successfully transplanted with a myeloablative conditioning regimen and peripheral blood stem cells of a matched donor. We believe that allogeneic HSCT is a reasonable therapeutic approach for patients with very severe CDA, even if only a matched unrelated donor is available.

Keywords: CDA; congenital dyserythropoietic anemia type II; fetal hydrops; unrelated HSCT.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Dyserythropoietic, Congenital / therapy*
  • Blood Transfusion, Intrauterine*
  • Combined Modality Therapy
  • Female
  • Humans
  • Infant
  • Pregnancy
  • Prognosis
  • Stem Cell Transplantation*
  • Transplantation Conditioning